Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

primary cutaneous amyloidosis - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

primary cutaneous amyloidosis

MONDO:0015301

Also known as:primary localised cutaneous amyloidosisprimary localized cutaneous amyloidosisPLCA

Find Clinical TrialsTrials

Overview

Cutaneous amyloidosis refers to a variety of skin diseases characterized histologically by the extracellular accumulation of amyloid deposits in the dermis. Rare forms include lichen amyloidosus, X-linked reticulate pigmentary disorder, primary localized cutaneous nodular amyloidosis, and macular amyloidosis.

Clinical Trials2 registered · 1 recruiting

Diagnosis

Biomarker and diagnostic research for primary cutaneous amyloidosis has been reported in the published literature.

Prognosis

Estimated prevalence: Unknown (Unknown prevalence).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy, other interventions, and biologic therapy. Pipeline includes 1 PHASE4, 1 NA. Research is primarily sponsored by academic and government institutions.

45 publications have been identified in PubMed for primary cutaneous amyloidosis. Research spans Case Report / Case Series (58%), Review / Meta-Analysis (13%), and Diagnostic / Biomarker (11%).

Research Type	Count	% of Total
Patient case studies	26

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 9:25 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:137807

GARD

Genetic and Rare Diseases Info Center

GARD:132

Questions for Your Care Team

→Are any of the 2 active clinical trials a good fit for my situation?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

primary cutaneous amyloidosis

Overview

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Recent Publications